The $10 billion price rested on optimistic assumptions about Metseras future performance, estimating Pfizer would need to generate about $11 billion in revenue from the deal by 2040 nearly double Metseras current projections, Courtney Breen, an analyst at Bernstein, said
Speak with a provider first if you have: A history of cancer or active malignancy Uncontrolled diabetes or blood sugar concerns Severe swelling or fluid retention Sleep apnea or breathing concerns Significant heart, kidney, or liver disease Pregnancy, breastfeeding, or pregnancy plans Severe headaches or vision changes Current hormone-related treatment A history of allergic reactions to injections Unverified peptide products purchased online A provider can help decide whether Ipamorelin is appropriate, whether lab review is needed, and whether another peptide therapy option may be safer
Additionally, changes in intestinal permeability could exacerbate neuroimmune dysregulation by allowing transmucosal passage of injurious or immunogenic antigens
This wider therapeutic value makes up for the higher initial cost for many patients who want to improve their overall health
